Sort
53,477 grants matching “addiction”
Functionally selective D2Rs, striatal circuit function and motivation
$612,525Christoph Kellendonk · New York State Psychiatric Institute Dba Research Foundation For Mental Hygiene, Inc · R01 · FY2020 · MH
A Randomized Trial of Concurrent Treatment for PTSD and Substance Dependence
$612,351Denise Aimee Hien · City College Of New York · R01 · FY2009 · DA
Pharmacological Treatment of Cannabis Withdrawal and Dependence
$612,325Barbara J Mason · Scripps Research Institute, The · R01 · FY2010 · DA
Disease Management for Chronic Drug Abuse
$612,241Jon Morgenstern Morgenstern · Partnership To End Addiction · R01 · FY2011 · DA
Non-opiate treatment after prenatal opiate exposure to Prevent Postnatal Injury to the Young Brain (No-POPPY)
$612,116Henrietta S. Bada · University Of Kentucky · R01 · FY2017 · DA
Comparing Interventions for Opioid Dependent Patients Presenting in Medical EDs
$612,048Michael Parks Bogenschutz · University Of New Mexico Health Scis Ctr · R01 · FY2013 · DA
Small molecule modulators of ÎFosB function
$611,917Gabrielle Rudenko · University Of Texas Med Br Galveston · R01 · FY2019 · DA
Anti-inflammatory therapy to improve outcomes in patients with chronic pancreatitis undergoing total pancreatectomy with islet autotransplant (TPIAT)
$611,913Melena D. Bellin · University Of Minnesota · R01 · FY2016 · DK
Neurodevelopmental Effects of Cannabis and its Epigenetic Regulation
$611,891Yasmin L Hurd · Icahn School Of Medicine At Mount Sinai · R01 · FY2016 · DA
Clinical Trials Network: Pacific Northwest Node
$611,888Dennis M Donovan · University Of Washington · UG1 · FY2018 · DA
A Longitudinal Prospective Study of Social Network Dynamics in Addictions
$611,881Robert L Stout · Pacific Institute For Res And Evaluation · R01 · FY2012 · DA
HIV, Buprenorphine, and the Criminal Justice System
$611,814Frederick Lewis Altice · Yale University · R01 · FY2014 · DA
Impact of comorbidity of HIV infection and substance use disorder on brain aging and cognitive impairment
$611,534Yihong Yang · National Institute On Drug Abuse · ZIA · FY2025 · DA
Motivational Interviewing: An Experiential Online Training Tool
$611,523Jeffrey Olivet · C4 Innovations, Llc · R44 · FY2014 · MH
3/11 Epigenetic Regulation of Neuroimmune Pathways
$611,506Sean P Farris · University Of Pittsburgh At Pittsburgh · U01 · FY2024 · AA
MEDICATION DEVELOPMENT FOR PROTRACTED ABSTINENCE IN ALCO
$611,327University Of Miami School Of Medicine · R01 · FY2001 · AA
Brain reorganization in chronic back pain and opioid exposure
$611,247Apkar Vania Apkarian · Northwestern University At Chicago · P50 · FY2020 · DA
Pretreatment Changes in Drinking: A Test of a Tailored Treatment Approach
$611,194Paul R Stasiewicz · State University Of New York At Buffalo · R01 · FY2017 · AA
Linking Russian Narcology & HIV Care to Enhance Treatment, Retention, & Outcomes
$611,168Jeffrey H Samet · Boston Medical Center · R01 · FY2013 · DA
Identifying genomic loci related to vulnerability to opioid addiction
$611,166Jonathan Gewirtz · University Of Minnesota · U01 · FY2022 · DA
Translational Neuropsychopharmacology Research of Nicotine Addiction
$611,155Brett Froeliger · Medical University Of South Carolina · R01 · FY2017 · DA
Prospective Memory in HIV-1 Infection
$611,149Steven P Woods · University Of California, San Diego · R01 · FY2008 · MH
HIT TO LEAD CHEMISTRY UNDER PERFORMANCE AREA 2 OF ID/IQ CONTRACT NO. HHSN271201800001I
$611,149Matt Surman · Albany Molecular Research, Inc. · N01 · FY2025 · DA
Naltrexone and Behavioral Drug and HIV Risk Reduction Counseling in Russia
$611,135Marek C Chawarski · Yale University · R01 · FY2011 · DA
Peptidic Kappa Opioid Receptor Ligands as Potential Treatments for Drug Addiction
$611,074Jane V Aldrich · University Of Florida · R01 · FY2017 · DA